Ideastream's Rick Jackson talked with the Plain Dealer's Angela Townsend about her article, which outlines that in some ways, a local researcher's cancer fighting vaccine is being shelved because of paperwork, too little funding, and internal medicinal politics.
But he's not quitting. The conversations begins with who Vincent Tuohy is... and why he thought he was on the verge of a breakthrough.
His work is different from some 'traditional' studies, drawing skepticism in some circles.
He would need $6 to 10 million for conducting a clinical trial approved by the FDA, and is not getting support to raise it except for incidentals, from individuals who believe - and some from the Cleveland Clinic, which provides resources, but cannot provide that kind of cash.
He's even gone to China this spring seeking big-donor support.